
Biogen, Eisai, Aardvark Therapeutics, etc.
Stay informed on the latest in biotech by signing up for the newsletter. Recent developments include scientists discovering a way to target aggressive pediatric tumor cells using tumor-suppressor genes. A U.K. health agency’s decision on an ALS drug by Biogen raises concerns about access to genetic medicines. Generic versions of diabetes drugs could be more…